Open Access Pub publishes peer-reviewed, free-to-read open-access articles. Showing
articles matching Sickle Cell Disease — open any to read the full text,
or download the PDF or XML.
Dec 2025 DOI 10.14302/issn.2997-1977.jd-25-5754
Valentine Olagunju GraceCorresponding author
With more than 150,000 affected infants annually, Nigeria bears the largest burden worldwide of sickle cell disease (SCD), making it a significant public health concern. The management of SCD in Nigeria is challenging, despite advancements in medical research and increased knowledge. This review examines the numerous issues surrounding SCD in the nation, including the financial burden on affected families, the lack of specialized care facilities, the absence of newborn screening programs, the sociocultural stigmatization of SCD, and restricted access to high-quality healthcare. Additionally, inadequate public health education and a lack of coordinated national policies result in delayed diagnosis and suboptimal treatment outcomes. We also highlighted recent efforts and recommendations aimed at improving early detection, comprehensive care, and community support. Addressing these challenges through expanded health education and enhanced healthcare infrastructure is essential to reducing morbidity and mortality associated with SCD in Nigeria.
Sep 2014 DOI 10.14302/issn.2372-6601.jhor-14-499
L. Edwards ChristopherCorresponding author
Department of Psychiatry, Division of Medical Psychology, Duke University Medical Center.
Medical advances in obstetrics and hematology have encouraged researchers to investigate the reproductive risk in women with Sickle Cell Disease (SCD) attempting motherhood. However, few hematological studies have been completed focused specifically on the reproductive mental health of Black women with SCD. Historically women with SCD have been guided away from childbirth under the premise that they were not emotionally or physically capable of managing children. One question that remains unclear, from the limited research available in this area, is whether the presence of children serves to influence mood and pain in Black women with SCD. The current study examined the effects of the presence of children on self-reported pain and depressive symptoms and the relationship between pain and psychological functioning in African American women with SCD. Self-reported rates of depression, pain intensity, and pain severity were evaluated in 70 African American females with SCD. Results of Analysis of Covariance (ANCOVA) did not find differences in reported mood or pain between women with and without children. The current study serves as an initial observation upon which replication of the current findings and future prospective studies can be conducted. The study may ultimately mature into an area of research that guides reproductive decision-making for women with SCD and their doctors.
Nov 2023 DOI 10.14302/issn.2997-1969.ijhs-23-4628
S. Oluwafemi OyamakinCorresponding author
Gene alterations that are essentially present in every cell in the body cause many hereditary diseases. As a result, these ailments frequently impact many bodily systems, and the majority of them are incurable. To treat or manage some of the accompanying symptoms, there might be methods available. When monitored up to the age of 25, it is estimated that 5.3% of babies will experience a genetic disease. In order to build a modified intervention program for people with genetic disorders, this paper reviewed existing programs and interventions for people with genetic disorders. It did this by using information about sickle cell disease. Data was gathered at the sickle cell clinic at the State Hospital, Adeoyo, Ibadan, Oyo state, where all sickle cell patients receive care. 53.3% of the survey participants were male (n=81), whereas 46.7% of the participants were female (n=71). In terms of age, 59.2% (n=90) of the respondents are under 20 years old, 27.6% (n=42) are between 21 and 26 years old, 9.9% (n=15) are between 26 and 30 years old, 1.3% (n=2) are between 31 and 35 years old, and 0.7% (n=1) of the respondents are each in the age brackets of 36 to 40, 41 to 45, and over 45. This demonstrates that the age range between 0 and 30 years old has the highest percentage of respondents, whereas people older than 30 are infrequently found. The respondents' marital status was also taken into account; 91.4% (n=139) of them are single, 7.2% (n=11) are married, and 1.3% (n=2) are separated.
Apr 2020 DOI 10.14302/issn.2372-6601.jhor-20-3189
Mamadou Sekongo YassonguiCorresponding author
Department of Training and Research, National Blood Transfusion Center; Abidjan; Côte D’Ivoire
This article has been retracted on 29 January 2021. VIEW THE RETRACTION NOTICE (https://doi.org/10.14302/issn.2372-6601.jhor-25-5854) In Côte d'Ivoire, sickle cell disease affects 14% of the population. It is responsible for significant morbidity and mortality. Transfusion is a significant element in the management of major sickle cell anemia, which exposes them to post-transfusion hemochromatosis. The biological diagnosis is based on the determination of serum iron and the transferrin saturation coefficient (CST). As the determination of the CST was not available in our exercise context in Côte d'Ivoire, we determined only the ferritinemia. The interest of this work lies in the therapeutic implication linked to the identification of patients at risk of hemochromatosis because chelators are difficult to access for most patients. This was a prospective, descriptive and analytical study, on polytransfused sickle cell patients, followed at the transfusion therapy unit (UTT) of the CNTS of Abidjan, from 2010 to 2018. We included 78 sickle cell patients, all ages and genders who have received at least ten transfusions. The ferritinemia assay was carried out by ELISA. Transfusion exchange, with 59% of cases, was the most used mode of transfusion. The mean ferritinemia was 1719.19 ng / ml. Hyperferritinemia was found in 63% of patients. Most of the patients were on a long-term transfusion program with an average of 27.5 bags of red blood cell concentrates. Thirty-two patients had received at least 20 bags of red blood cell concentrates. We noted 21 patients treated, including 3 with deferoxamine and 18 treated with oral deferasirox. We have identified 33 sickle cell anemia patients at risk for hemochromatosis. The determinants of the risk of hemochromatosis were the high number of blood bags and the method of transfusion.